Literature DB >> 12047141

Development of a high-pressure liquid chromatography method for diagnosis of heparin-induced thrombocytopenia.

Sandra Koch1, Job Harenberg, Michael Odel, Heinrich Schmidt-Gayk, Stefan Walch, Uwe Budde.   

Abstract

Owing to the disadvantage of radioactivity of the carbon 14 serotonin release assay and the time-consuming procedure of the enzyme immunoassay, we developed a high-pressure liquid chromatography (HPLC) method to detect serotonin released from donor platelets in the presence of heparins and serum samples from patients with heparin-induced thrombocytopenia (HIT). Samples were analyzed from 60 healthy control subjects, 19 patients with HIT, and 20 patients without HIT after incubation with heparin, low-molecular-weight heparin (LMWH), and danaparoid. Serotonin release was measured from platelets, 300 x 10(3)/microL, by HPLC. Serotonin eluted as a single peak from the HPLC column. Serum samples from patients with HIT released 5.5 to 352.5 and 6.6 to 1,533.3 ng/mL of serotonin from platelets in the presence of 0.2 IU/mL of heparin and LMWH, respectively. In the presence of 0 IU/mL of heparin, LMWH, danaparoid, and control samples, less than 2.5 ng/mL of serotonin were released. The HPLC method permits a rapid, sensitive, and quantitative determination of serotonin released from donor platelets for laboratory confirmation of HIT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047141     DOI: 10.1309/4XUM-4M9U-G3D3-5JKF

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

Review 1.  Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors:  Albrecht Leo; Susanne Winteroll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

2.  False positive immunoassay for heparin-induced thrombocytopenia in the presence of monoclonal gammopathy: a case report.

Authors:  Ivana Markovic; Zeljko Debeljak; Bojana Bosnjak; Maja Marijanovic
Journal:  Biochem Med (Zagreb)       Date:  2017-10-15       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.